Airway nitrergic pathways: Is there therapeutic potential in asthma and COPD?

Current Opinion in Pharmacology

Volumn 4, Issue 3, 2004, Pages 202-206

  Folkerts, Gert ^a   Nijkamp, Frans P ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; ARGINASE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; ENZYME INHIBITOR; N ACETYL S NITROSOPENICILLAMINE; N(G) HYDROXYARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PARACETAMOL; PREDNISOLONE; SALBUTAMOL;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; EOSINOPHIL; HUMAN; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; NEUTROPHIL; NITRERGIC NERVE; OXIDATIVE STRESS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SYMPTOMATOLOGY; TISSUE INJURY; WESTERN HEMISPHERE;

EID: 2342597109     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2004.01.005     Document Type: Review

References (49)

1. Smit J.J. Folkerts G. Nijkamp F.P. Mycobacteria, genes and the 'hygiene hypothesis' Curr Opin Allergy Clin Immunol 4 2004 57-62
2. Ten Broeke R. Blalock J. Nijkamp F. Folkerts G. Calcium sensors as new therapeutic targets for asthma and COPD Clin Exp Allergy 34 2004 170-176
3. Luhrs H. Papadopoulos T. Schmidt H. Menzel T. Type I nitric oxide oxide synthase in the human lung is predominantly expressed in capillary endothelial cells Respir Physiol 129 2002 367-374
4. Fischer A. Folkerts G. Geppetti P. Mediators of asthma: nitric oxide Pulm Pharmacol Ther 15 2002 73-81
5. Kesler BS MSaCB: Nitric oxide-dependent modulation of smooth muscle tone by airway parasympatic nerves. Am J Respir Crit Care Med 2002, 165:481-488.
6. Ricciardolo F. Sterk P. Gaston B. Folkerts G. Nitric oxide in health and disease of the respiratory system Physiol Rev 84 2004 1-35
7. Nevin B.J. Broadley K.J. Nitric oxide in respiratory diseases Pharmacol Ther 95 2002 259-293
8. Braun A. Nockher W.A. Renz H. Control of nerve growth and plasticity Curr Opin Pharmacol 2 2002 229-234
9. Henricks PAJ, Folkerts G, Nijkamp FP: Asthma and oxidative stress. In: Oxygen/nitrogen radicals: Lung injury and disease. Edited by Vallyathan V. New York: Marcel Dekker; 2004.
10. Andersson C. Gaston B. Roomans G. S-Nitrosoglutathione induces functional F508 CFTR in cultured airway epithelial cells Biochem Biophys Res Commun 297 2002 552-557
11. Howard M. Fischer H. Roux J. Santos B.C. Gullans S.R. Yancey P.H. Welch W.J. Mammalian osmolytes and S-nitrosoglutathione promote Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) protein maturation and function J Biol Chem 278 2003 35159-35167
12. Kloek J. Van Ark I. De Clerck F. Bloksma N. Nijkamp F.P. Folkerts G. Modulation of airway hyperresponsiveness by thiols in a murine in vivo in allergic asthma Inflamm Res 52 2003 126-131
13. Gaston B. Functional genomics and proteomics in control of breathing Respir Physiol Neurobiol 135 2003 231-238
14. Kloek J. Van Ark I. Bloksma N. De Clerck F. Nijkamp F.P. Folkerts G. Glutathione and other low-molecular-weight thiols relax guinea pig trachea ex vivo: interactions with nitric oxide? Am J Physiol Lung Cell Mol Physiol 283 2002 L403-L408
15. Snyder A. McPherson M.E. Hunt J.F. Johnson M. Stamler J.S. Gaston B. Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis Am J Respir Crit Care Med 165 2002 1-5
16. Andreadis A.A. Hazen S.L. Comhair S.A. Erzurum S.C. Oxidative and nitrosative events in asthma Free Radic Biol Med 35 2003 213-225
17. Payne D.N.R. Nitric oxide in allergic airway inflammation Curr Opin Allergy Clin Immunol 3 2003 133-137
18. Ricciardolo F.L. Timmers M.C. Sont J.K. Folkerts G. Sterk P.J. Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma Thorax 58 2003 840-845
19. Coleman J.W. Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation Clin Exp Immunol 129 2002 4-10
20. Ricciardolo F.L. cNOS-iNOS paradigm and arginase in asthma Trends Pharmacol Sci 24 2003 560-561
21. Meurs H. McKay S. Maarsingh H. Hamer M.A. Macic L. Molendijk N. Zaagsma J. Increased arginase activity underlies allergen-induced deficient cNOS-derived nitric oxide and airway hyperresponsiveness Br J Pharmacol 136 2002 391-398
22. Zimmerman N. King N.E. Laporte J. Yang M. Mishra A. Pope S.M. Muntel E.E. Wit D.P. Pegg A.A. Foster P.S. Hamid Q. Rothenberg M.E. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis J Clin Invest 111 2003 1863-1874
23. Colpaert E.E. Lefebre R.A. Role of antioxidants in the protection of the nitrergic neurotransmitter Acta Neurol Belg 102 2002 68-72
24. Brunini T.M. Yaqoob M.M. Novaes Malagris L.E. Ellory J.C. Mann G.I. Mendes Ribeiro A.C. Increased nitric oxide synthesis in uraemic platelets is dependent L-arginine transport via system y(+)L Pflugers Arch 445 2003 547-550
25. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system Prog Neurobiol 64 2001 365-391
26. Do K.Q. Grima G. Benz B. Salt T.E. Glial-neuronal transfer of arginine and S-nitrosothiols in nitric oxide transmission Ann N Y Acad Sci 962 2002 81-92
27. Hopkin J. The rise of atopy and links to infection Allergy 57 2002 5-9
28. Ali M. Khoo S.K. Turner S. Stick S. Le Souef P. Franklin P. NOS1 polymorphism is associated with atopy but not exhaled oxide levels in healthy children Pediatr Allergy Immunol 14 2003 261-265
29. Hasaneen N.A. Foda H.D. Said S.I. Nitric oxide and vasoactive intestinal peptide as co-transmitters of airway smooth-muscle relaxation; analysis in neuronal nitric oxide synthase knockout mice Chest 124 2003 1067-1072
30. Kharitonov S.A. Barnes P.J. Nitric oxide, nitrotyrosine, and nitric oxide modulators in astma and chronic obstructive pulmonary disease Curr Allergy Asthma Rep 3 2003 121-129
31. Jang A.S. Choi I.S. Lee J.U. Neuronal nitric oxide synthase is associated with airway obstruction in BALB/c mice exposed to ozone Respiration 70 2003 95-99
32. Barreiro E. Gea J. Corominas J.M. Hussain S.N.A. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 29 2003 771-778
33. Vonbank K. Ziesche R. Higenbottam T. Stiebellehner L. Petkov V. Schenk P. Germann P. Block L. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD Thorax 58 2003 289-293
34. Clark R. Huckaby J. Kueser T. Walker M. Southgate W. Perez J. Roy B. Keszler M. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up J Perinatol 23 2003 300-303
35. Moya M. Gow A. Califf R. Goldberg R. Stamler J. Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn Lancet 360 2002 2076-2077
36. Megson I. Webb D. Nitric oxide donor drugs: current status and future trends Expert Opin Investig Drugs 11 2002 587-601
37. Keeble J.E. Moore P.K. Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs Br J Pharmacol 137 2002 295-310
38. Malmstrom R.E. Tornberg D.C. Settergren G. Liska G. Angdin M. Lundberg J.O. Weitzberg E. Endogenous nitric oxide release by vasoactive drugs monitored in exhaled air Am J Respir Crit Care Med 168 2003 114-120
39. Manion M.K. Villain M. Pan Z.G. McDonald J.M. Blalock J.E. Cellular uptake and in situ binding of a peptide agonist for calmodulin Biochem Biophys Res Commun 277 2000 462-469
40. Villain M. Jackson P.L. Manion M.K. Dong W.J. Su Z. Fassina G. Johnson T.M. Sakai T.T. Krishna N.R. Blalock J.E. De novo design of peptides targeted to the EF hands of calmodulin J Biol Chem 275 2000 2676-2685
41. Ten Broeke R.T. Leusink-Muis T. Hilberdink R. Van Ark I. Van Den Worm E. Villain M. De Clerck F. Blalock J.E. Nijkamp F.P. Folkerts G. Specific modulation of calmodulin activity induces a dramatic production of superoxide by alveolar macrophages Lab Invest 84 2004 29-40
42. 2+ sensors modulate asthmatic symptoms in an allergic model for asthma Eur J Pharmacol 476 2003 151-157
43. Ten Broeke R. Folkerts G. Leusink-Muis T. Vander Linde H. Villain M. Manion M. De Clerck F. Blalock J. Nijkamp F. Calcium sensors as new therapeutic targets for airway hyperresponsiveness and asthma FASEB J 15 2001 1831-1833
44. Meurs H. Maarsingh H. Zaagsma J. Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness Trends Pharmacol Sci 24 2003 450-455
45. Vercelli D. Arginase: marker, effector, or candidate gene for asthma? J Clin Invest 111 2003 1815-1817
46. Champion H.C. Bivalacqua T.J. Greenberg S.S. Giles T.D. Hyman A.L. Kadowitz P.J. Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice Proc Natl Acad Sci USA 99 2002 13248-13253
47. Bates C.A. Silkoff P.E. Exhaled nitric oxide in asthma: from bench to bedside J Allergy Clin Immunol 111 2003 256-262
48. Kaisers U. Busch T. Deja M. Donaubauer B. Falke K.J. Selective pulmonary vasodilation in acute respiratory distress syndrome Crit Care Med 31 2003 S337-S347
49. Hansel T. Kharitonov S.A. Donnely L.E. Erin E.M. Currie M.G. Moore W.M. Manning P.T. Recker D.P. Barnes P.J. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics Faseb J 17 2003 1298-1300